533 related articles for article (PubMed ID: 27340022)
1. The mTOR signalling cascade: paving new roads to cure neurological disease.
Crino PB
Nat Rev Neurol; 2016 Jul; 12(7):379-92. PubMed ID: 27340022
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin (mTOR) pathways in neurological diseases.
Wong M
Biomed J; 2013; 36(2):40-50. PubMed ID: 23644232
[TBL] [Abstract][Full Text] [Related]
3. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
Maiese K
Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin and tuberous sclerosis complex.
Wataya-Kaneda M
J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
[TBL] [Abstract][Full Text] [Related]
5. The neurology of mTOR.
Lipton JO; Sahin M
Neuron; 2014 Oct; 84(2):275-91. PubMed ID: 25374355
[TBL] [Abstract][Full Text] [Related]
6. Focal malformations of cortical development: new vistas for molecular pathogenesis.
Lim KC; Crino PB
Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin (mTOR) signaling pathway and traumatic brain injury: A novel insight into targeted therapy.
Movahedpour A; Vakili O; Khalifeh M; Mousavi P; Mahmoodzadeh A; Taheri-Anganeh M; Razmeh S; Shabaninejad Z; Yousefi F; Behrouj H; Ghasemi H; Khatami SH
Cell Biochem Funct; 2022 Apr; 40(3):232-247. PubMed ID: 35258097
[TBL] [Abstract][Full Text] [Related]
9. mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.
Ryskalin L; Limanaqi F; Frati A; Busceti CL; Fornai F
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061532
[TBL] [Abstract][Full Text] [Related]
10. The mTOR pathway is activated in glial cells in mesial temporal sclerosis.
Sosunov AA; Wu X; McGovern RA; Coughlin DG; Mikell CB; Goodman RR; McKhann GM
Epilepsia; 2012 Jun; 53 Suppl 1():78-86. PubMed ID: 22612812
[TBL] [Abstract][Full Text] [Related]
11. Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components.
Saxena A; Sampson JR
Semin Cell Dev Biol; 2014 Dec; 36():140-6. PubMed ID: 25263008
[TBL] [Abstract][Full Text] [Related]
12. Focal brain malformations: a spectrum of disorders along the mTOR cascade.
Crino PB
Novartis Found Symp; 2007; 288():260-72; discussion 272-81. PubMed ID: 18494264
[TBL] [Abstract][Full Text] [Related]
13. The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.
Curatolo P; Bjørnvold M; Dill PE; Ferreira JC; Feucht M; Hertzberg C; Jansen A; Jóźwiak S; Kingswood JC; Kotulska K; Macaya A; Moavero R; Nabbout R; Zonnenberg BA
Drugs; 2016 Apr; 76(5):551-65. PubMed ID: 26927950
[TBL] [Abstract][Full Text] [Related]
14. GATOR1 complex: the common genetic actor in focal epilepsies.
Baldassari S; Licchetta L; Tinuper P; Bisulli F; Pippucci T
J Med Genet; 2016 Aug; 53(8):503-10. PubMed ID: 27208208
[TBL] [Abstract][Full Text] [Related]
15. Abnormal mTOR Activation in Autism.
Winden KD; Ebrahimi-Fakhari D; Sahin M
Annu Rev Neurosci; 2018 Jul; 41():1-23. PubMed ID: 29490194
[TBL] [Abstract][Full Text] [Related]
16. Role of mTOR in physiology and pathology of the nervous system.
Swiech L; Perycz M; Malik A; Jaworski J
Biochim Biophys Acta; 2008 Jan; 1784(1):116-32. PubMed ID: 17913600
[TBL] [Abstract][Full Text] [Related]
17. Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders.
Gipson TT; Johnston MV
Neural Plast; 2012; 2012():486402. PubMed ID: 22619737
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling in epilepsy: insights from malformations of cortical development.
Crino PB
Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
[TBL] [Abstract][Full Text] [Related]
19. [Dysregulation of the mTOR signaling pathway in the pathogenesis of autism spectrum disorders].
Gabryel B; Kapałka A; Sobczyk W; Łabuzek K; Gawęda A; Janas-Kozik M
Postepy Hig Med Dosw (Online); 2014 Apr; 68():375-83. PubMed ID: 24864089
[TBL] [Abstract][Full Text] [Related]
20. [Autism, epilepsy and tuberous sclerosis complex: a functional model linked to mTOR pathway].
García-Peñas JJ; Carreras-Sááez I
Rev Neurol; 2013 Feb; 56 Suppl 1():S153-61. PubMed ID: 23446718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
